Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of BBI-4000 gel in Japanese patients with primary focal hyperhidrosis
jRCT2071210041Completed
- Sponsor
- Kaken Pharmaceutical Co., Ltd.
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of sofpironium in Primary hyperhidrosis (PH) (3 arms), sponsored by Kaken Pharmaceutical Co., Ltd. Primary endpoints: Plasma concentrations of BBI-4000 and Pharmacokinetic parameters of BBI-4000. Started Jul 2021; status: completed.
02
Drugs
sofpironium
03
Conditions
Primary hyperhidrosis (PH)
Beyond the preview
Go deeper on jRCT2071210041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210041.